| Saham Orang Dalam | 26,630,802 shares |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
N/A
Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
N/A
Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Radius Recycling, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di RDUS / Radius Recycling, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di RDUS / Radius Recycling, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-30 | 2022-08-11 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 10.0000 | -8,733,538 | -87,335 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Common Stock | D | 10.0000 | -5,500 | -55 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Murphy Sean | RDUS | Common Stock | D | 10.0000 | -5,500 | -55 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 10.0000 | -5,500 | -55 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 10.0000 | -26,800 | -268 | 5,500 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Martin G. Kelly | RDUS | Common Stock | D | 10.0000 | -75,000 | -750 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Holtschlag Danielle | RDUS | Common Stock | D | 10.0000 | -25,000 | -250 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Messersmith Elizabeth | RDUS | Common Stock | D | 10.0000 | -70,000 | -700 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Hughes Owen | RDUS | Common Stock | D | 10.0000 | -21,650 | -216 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Dere Willard H | RDUS | Common Stock | D | 10.0000 | -1,895 | -19 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Dere Willard H | RDUS | Common Stock | D | 10.0000 | -21,300 | -213 | 1,895 | ||||
| 2022-08-15 | 2022-08-15 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 10.0000 | -26,800 | -268 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | Shah Chhaya | RDUS | Common Stock | D | 10.0000 | -94,645 | -946 | 0 | ||||
| 2022-08-15 | 2022-08-15 | 4 | SANDERS MACHELLE | RDUS | Common Stock | D | 10.0000 | -5,500 | -55 | 0 | ||||
| 2022-08-12 | 2022-08-11 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 10.0700 | 1,678,954 | 16,907 | 8,642,271 | ||||
| 2022-08-11 | 2022-08-10 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 10.0700 | 4,012 | 40 | 6,963,317 | ||||
| 2022-05-20 | 2022-05-18 | 4 | Lisa Susan Vissers | RDUS | Stock Option (Right to Buy) | D | 5.84 | 30,000 | 30,000 | |||||
| 2022-05-20 | 2022-05-18 | 4 | Jarrett Jennifer | RDUS | Stock Option (Right to Buy) | D | 5.84 | 30,000 | 30,000 | |||||
| 2022-05-20 | 2022-05-18 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 5.5690 | 477,824 | 2,661 | 8,733,538 | ||||
| 2022-03-17 | 2022-03-15 | 4 | Conley Mark William | RDUS | Common Stock | D | 50,000 | 50,000 | ||||||
| 2022-02-28 | 3 | Messersmith Elizabeth | RDUS | Common Stock | D | 70,000 | ||||||||
| 2022-02-25 | 2022-02-21 | 4 | Martin G. Kelly | RDUS | Common Stock | D | 75,000 | 75,000 | ||||||
| 2022-02-23 | 2022-02-21 | 4 | Martin G. Kelly | RDUS | Common Stock | D | 960,000 | 960,000 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Helwig Steven | RDUS | Common Stock | D | 15,000 | 31,251 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | SANDERS MACHELLE | RDUS | Stock Option (Right to Buy) | D | 6.40 | 10,000 | 10,000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | SANDERS MACHELLE | RDUS | Common Stock | D | 5,500 | 5,500 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 6.40 | 10,000 | 10,000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | Hughes Owen | RDUS | Common Stock | D | 5,500 | 21,650 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Stock Option (Right to Buy) | D | 6.40 | 10,000 | 10,000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Common Stock | D | 5,500 | 5,500 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Shah Chhaya | RDUS | Common Stock | D | 65,000 | 94,645 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 6.40 | 10,000 | 10,000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5,500 | 26,800 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 6.40 | 10,000 | 10,000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | Dere Willard H | RDUS | Common Stock | D | 5,500 | 23,195 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 6.40 | 10,000 | 10,000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5,500 | 26,800 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Holtschlag Danielle | RDUS | Common Stock | D | 25,000 | 25,000 | ||||||
| 2022-01-25 | 2022-01-14 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 6.40 | 10,000 | 10,000 | |||||
| 2022-01-25 | 2022-01-14 | 4 | Murphy Sean | RDUS | Common Stock | D | 5,500 | 11,000 | ||||||
| 2022-01-07 | 2022-01-06 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 6.3147 | 300,000 | 1,894 | 8,255,714 | ||||
| 2022-01-07 | 2022-01-05 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 6.2986 | 250,000 | 1,575 | 7,955,714 | ||||
| 2021-12-16 | 2021-12-16 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 7.0747 | 146,685 | 1,038 | 6,959,305 | ||||
| 2021-12-15 | 2021-12-15 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 6.7700 | 180,744 | 1,224 | 6,812,620 | ||||
| 2021-12-15 | 2021-12-14 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 6.8110 | 94,103 | 641 | 6,631,876 | ||||
| 2021-12-15 | 2021-12-13 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 7.0804 | 187,391 | 1,327 | 6,537,773 | ||||
| 2021-12-10 | 2021-12-10 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 7.1750 | 768,171 | 5,512 | 6,350,382 | ||||
| 2021-12-10 | 2021-12-09 | 4 | Rubric Capital Management LP | RDUS | Common Stock | I | 7.5841 | 264,644 | 2,007 | 5,582,211 | ||||
| 2021-12-10 | 2021-12-08 | 4 | Rubric Capital Management LP | RDUS | Common Stock, par value $0.0001 per share ("Common Stock") | I | 8.0206 | 560,691 | 4,497 | 5,317,567 | ||||
| 2021-12-10 | 3 | Rubric Capital Management LP | RDUS | Common stock, par value $0.0001 per share | I | 4,756,876 | ||||||||
| 2021-10-18 | 2021-10-15 | 4 | Holtschlag Danielle | RDUS | Stock Option (Right to Buy) | D | 15.10 | 50,000 | 50,000 | |||||
| 2021-10-01 | 2021-09-29 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 12.9450 | 100,000 | 1,294 | 7,705,714 | ||||
| 2021-09-24 | 2021-09-22 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 12.2752 | 150,000 | 1,841 | 7,605,714 | ||||
| 2021-09-23 | 2021-05-17 | 4 | Shah Chhaya | RDUS | Common Stock | D | 10,000 | 29,645 | ||||||
| 2021-08-26 | 2021-08-24 | 4 | Helwig Steven | RDUS | Common | D | 5,125 | 20,829 | ||||||
| 2021-08-26 | 3 | Helwig Steven | RDUS | Common Stock | D | 15,704 | ||||||||
| 2021-03-24 | 3 | Shah Chhaya | RDUS | Common Stock | D | 19,645 | ||||||||
| 2021-03-24 | 2021-02-22 | 4/A | Martin G. Kelly | RDUS | Stock Option (Right to Buy) | D | 28.60 | 460,000 | 460,000 | |||||
| 2021-03-09 | 2021-03-05 | 4 | Chopas James George | RDUS | Common Stock | D | 20.8800 | -370 | -8 | 6,701 | ||||
| 2021-02-26 | 2021-02-25 | 4 | Grausso Sal | RDUS | Common Stock | D | 18.9300 | -1,322 | -25 | 11,709 | ||||
| 2021-02-23 | 2021-02-22 | 4 | Chopas James George | RDUS | Stock Option (Right to Buy) | D | 18.60 | 20,000 | 20,000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Grausso Sal | RDUS | Stock Option (Right to Buy) | D | 18.60 | 60,000 | 60,000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 18.60 | 10,000 | 10,000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Murphy Sean | RDUS | Common Stock | D | 5,500 | 5,500 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 18.60 | 10,000 | 10,000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Dere Willard H | RDUS | Common Stock | D | 5,500 | 17,695 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 18.60 | 10,000 | 10,000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5,500 | 21,300 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 18.60 | 10,000 | 10,000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5,500 | 21,300 | ||||||
| 2021-02-23 | 2021-02-22 | 4 | Martin G. Kelly | RDUS | Stock Option (Right to Buy) | D | 28.60 | 460,000 | 460,000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 18.60 | 10,000 | 10,000 | |||||
| 2021-02-23 | 2021-02-22 | 4 | Hughes Owen | RDUS | Common Stock | D | 5,500 | 16,150 | ||||||
| 2021-01-25 | 2021-01-21 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 22.00 | 20,000 | 20,000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 22.00 | 20,000 | 20,000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 22.00 | 20,000 | 20,000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 22.00 | 20,000 | 20,000 | |||||
| 2021-01-25 | 2021-01-21 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 22.00 | 40,000 | 40,000 | |||||
| 2021-01-21 | 2021-01-20 | 4 | Chopas James George | RDUS | Stock Option (Right to Buy) | D | 21.66 | 20,000 | 20,000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | VON ESCHENBACH ANDREW C. | RDUS | Stock Option (Right to Buy) | D | 18.17 | 30,000 | 30,000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | SANDERS MACHELLE | RDUS | Stock Option (Right to Buy) | D | 18.17 | 30,000 | 30,000 | |||||
| 2020-12-18 | 3 | Chopas James George | RDUS | Common Stock | D | 1,492 | ||||||||
| 2020-11-10 | 2020-11-09 | 4 | Dolan Dan | RDUS | Stock Option (Right to Buy) | D | 14.08 | 12,000 | 12,000 | |||||
| 2020-11-10 | 2020-11-09 | 4 | Grausso Sal | RDUS | Stock Option (Right to Buy) | D | 14.08 | 15,000 | 15,000 | |||||
| 2020-11-10 | 3 | Grausso Sal | RDUS | Common Stock | D | 531 | ||||||||
| 2020-11-09 | 2020-11-05 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 14.2623 | 100,000 | 1,426 | 7,455,714 | ||||
| 2020-09-16 | 2020-09-14 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 11.6934 | 200,000 | 2,339 | 7,355,714 | ||||
| 2020-09-14 | 2020-09-11 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 11.3306 | 199,029 | 2,255 | 7,155,714 | ||||
| 2020-08-12 | 2020-08-10 | 4 | Murphy Sean | RDUS | Stock Option (Right to Buy) | D | 12.61 | 30,000 | 30,000 | |||||
| 2020-07-09 | 2020-07-08 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 13.2071 | 25,000 | 330 | 6,956,685 | ||||
| 2020-05-04 | 2020-04-30 | 4 | BIOTECH TARGET N V | RDUS | Common Stock | D | 15.7511 | 50,000 | 788 | 6,931,685 | ||||
| 2020-04-29 | 2020-04-28 | 4 | Martin G. Kelly | RDUS | Stock Option (Right to Buy) | D | 16.46 | 575,000 | 575,000 | |||||
| 2020-02-28 | 2020-02-26 | 4 | Carmona Jose | RDUS | Common Stock | D | 17.9330 | -1,292 | -23 | 46,708 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Dere Willard H | RDUS | Common Stock | D | 17.9500 | -1,925 | -35 | 12,195 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 17.9500 | -1,815 | -33 | 12,401 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Morris Charles Q | RDUS | Common Stock | D | 17.9330 | -1,256 | -23 | 33,744 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Hughes Owen | RDUS | Common Stock | D | 17.9500 | -2,750 | -49 | 10,650 | ||||
| 2020-02-28 | 2020-02-26 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 17.9330 | -889 | -16 | 24,111 | ||||
| 2020-02-24 | 2020-02-20 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 19.96 | 10,000 | 10,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5,500 | 15,800 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 19.96 | 10,000 | 10,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Graves Kurt | RDUS | Common Stock | D | 5,500 | 11,000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 19.96 | 107,000 | 107,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Hopfield Jessica | RDUS | Stock Option (Right to Buy) | D | 19.96 | 10,000 | 10,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Hopfield Jessica | RDUS | Common Stock | D | 5,500 | 18,300 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 19.96 | 10,000 | 10,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Hughes Owen | RDUS | Common Stock | D | 5,500 | 13,400 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 19.96 | 25,000 | 25,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 17,500 | 25,000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Morris Charles Q | RDUS | Stock Option (Right to Buy) | D | 19.96 | 30,000 | 30,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Morris Charles Q | RDUS | Common Stock | D | 20,000 | 35,000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 19.96 | 10,000 | 10,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 5,500 | 14,216 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 19.96 | 45,000 | 45,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Carmona Jose | RDUS | Common Stock | D | 30,000 | 48,000 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | Dere Willard H | RDUS | Common Stock (Right to Buy) | D | 19.96 | 10,000 | 10,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | Dere Willard H | RDUS | Common Stock | D | 5,500 | 14,120 | ||||||
| 2020-02-24 | 2020-02-20 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 19.96 | 10,000 | 10,000 | |||||
| 2020-02-24 | 2020-02-20 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5,500 | 15,800 | ||||||
| 2019-11-08 | 2019-11-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 23.0030 | 100,000 | 2,300 | 6,881,685 | ||||
| 2019-07-03 | 2019-07-01 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 24.6000 | -1,584 | -39 | 8,716 | ||||
| 2019-06-11 | 2019-06-07 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 21.8144 | 2,500 | 55 | 7,500 | ||||
| 2019-05-13 | 2019-05-10 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 21.4300 | 2,000 | 43 | 5,000 | ||||
| 2019-04-18 | 2019-04-16 | 4 | Dere Willard H | RDUS | Common Stock | D | 22.2200 | -1,680 | -37 | 8,620 | ||||
| 2019-04-18 | 2019-04-16 | 4 | Graves Kurt | RDUS | Common Stock | D | 22.3200 | -4,800 | -107 | 5,500 | ||||
| 2019-04-18 | 2019-04-16 | 4 | Hughes Owen | RDUS | Common Stock | D | 22.2200 | -2,400 | -53 | 7,900 | ||||
| 2019-04-12 | 2019-04-11 | 4 | Roychowdhury Debasish | RDUS | Common Stock | D | 22.1500 | -4,800 | -106 | 5,500 | ||||
| 2019-03-06 | 2019-03-05 | 4 | Hopfield Jessica | RDUS | Common Stock | D | 19.2336 | 12,800 | 246 | 12,800 | ||||
| 2019-02-26 | 2019-02-22 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 19.18 | 55,000 | 55,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Carmona Jose | RDUS | Common Stock | D | 15,000 | 18,000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 19.18 | 10,000 | 10,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Roychowdhury Debasish | RDUS | Common Stock | D | 5,500 | 10,300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 19.18 | 10,000 | 10,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 5,500 | 10,300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Morris Charles Q | RDUS | Stock Option (Right to Buy) | D | 19.18 | 55,000 | 55,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Morris Charles Q | RDUS | Common Stock | D | 15,000 | 15,000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 19.18 | 30,000 | 30,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 10,000 | 13,000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 19.18 | 10,000 | 10,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Hughes Owen | RDUS | Common Stock | D | 5,500 | 10,300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Hoiland Jesper | RDUS | Performance Stock Units | D | 71,000 | 71,000 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 19.18 | 128,000 | 128,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 19.18 | 55,000 | 55,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Hatzis-Schoch Brent | RDUS | Common Stock | D | 15,000 | 17,944 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Options (Right to Buy) | D | 19.18 | 10,000 | 10,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 5,500 | 10,300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 19.18 | 10,000 | 10,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 5,500 | 10,300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 19.18 | 10,000 | 10,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Graves Kurt | RDUS | Common Stock | D | 5,500 | 10,300 | ||||||
| 2019-02-26 | 2019-02-22 | 4 | Dere Willard H | RDUS | Common Stock (Right to Buy) | D | 19.18 | 10,000 | 10,000 | |||||
| 2019-02-26 | 2019-02-22 | 4 | Dere Willard H | RDUS | Common Stock | D | 5,500 | 10,300 | ||||||
| 2019-02-19 | 2019-02-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock Warrant (right to buy) | D | 14.00 | -71,409 | 0 | |||||
| 2019-02-19 | 2019-02-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 14.0040 | 71,409 | 1,000 | 6,781,685 | ||||
| 2019-02-13 | 2019-02-13 | 4 | Dere Willard H | RDUS | Restricted Stock Units | D | -4,800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Dere Willard H | RDUS | Common Stock | D | 4,800 | 4,800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | FRIEDMAN CATHY | RDUS | Restricted Stock Units | D | -4,800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | FRIEDMAN CATHY | RDUS | Common Stock | D | 4,800 | 4,800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Restricted Stock Units | D | -4,800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Common Stock | D | 4,800 | 4,800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Graves Kurt | RDUS | Restricted Stock Units | D | -4,800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Graves Kurt | RDUS | Common Stock | D | 4,800 | 4,800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Hughes Owen | RDUS | Restricted Stock Units | D | -4,800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Hughes Owen | RDUS | Common Stock | D | 4,800 | 4,800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Rosenberg Anthony | RDUS | Restricted Stock Units | D | -4,800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Rosenberg Anthony | RDUS | Common Stock | D | 4,800 | 4,800 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Roychowdhury Debasish | RDUS | Restricted Stock Units | D | -4,800 | 0 | ||||||
| 2019-02-13 | 2019-02-13 | 4 | Roychowdhury Debasish | RDUS | Common Stock | D | 4,800 | 4,800 | ||||||
| 2019-01-25 | 2019-01-24 | 4 | Hopfield Jessica | RDUS | Stock Option (Right to Buy) | D | 17.10 | 30,000 | 30,000 | |||||
| 2018-12-21 | 2018-12-20 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 14.4797 | 60,000 | 869 | 6,710,276 | ||||
| 2018-12-18 | 2018-12-17 | 4 | Kelly Joseph Francis | RDUS | Common Stock | D | 15.7100 | 3,000 | 47 | 3,000 | ||||
| 2018-12-17 | 2018-12-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 15.6376 | 60,000 | 938 | 6,650,276 | ||||
| 2018-09-05 | 2018-09-04 | 4 | Morris Charles Q | RDUS | Stock Option (Right to Buy) | D | 19.93 | 130,000 | 130,000 | |||||
| 2018-08-22 | 2018-08-20 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 19.6468 | 60,000 | 1,179 | 6,590,276 | ||||
| 2018-08-16 | 2018-08-15 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 20.7824 | 69,363 | 1,442 | 6,530,276 | ||||
| 2018-08-16 | 2018-08-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 20.8688 | 100,000 | 2,087 | 6,460,913 | ||||
| 2018-08-10 | 2018-08-08 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 22.7314 | 60,000 | 1,364 | 6,360,913 | ||||
| 2018-07-30 | 2018-07-27 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 24.8121 | 50,000 | 1,241 | 6,300,913 | ||||
| 2018-07-26 | 2018-07-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 27.2761 | 50,000 | 1,364 | 6,250,913 | ||||
| 2018-06-13 | 2018-06-11 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 27.3567 | 50,000 | 1,368 | 6,200,913 | ||||
| 2018-05-24 | 2018-05-23 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 28.9080 | 40,000 | 1,156 | 6,150,913 | ||||
| 2018-05-23 | 2018-05-21 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 29.2730 | 60,000 | 1,756 | 6,110,913 | ||||
| 2018-04-23 | 2018-04-19 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33.7984 | 40,000 | 1,352 | 6,050,913 | ||||
| 2018-04-16 | 2018-04-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock Warrant (right to buy) | D | 14.00 | -107,114 | 71,409 | |||||
| 2018-04-16 | 2018-04-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 14.0040 | 107,114 | 1,500 | 6,010,913 | ||||
| 2018-04-09 | 2018-04-05 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36.5769 | 50,000 | 1,829 | 5,903,799 | ||||
| 2018-03-06 | 2018-03-02 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32.5181 | 80,000 | 2,601 | 5,853,799 | ||||
| 2018-02-15 | 2018-02-13 | 4 | Roychowdhury Debasish | RDUS | Restricted Stock Units | D | 4,800 | 4,800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 37.83 | 8,800 | 8,800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 37.83 | 60,000 | 60,000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Dere Willard H | RDUS | Restricted Stock Units | D | 4,800 | 4,800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 37.83 | 8,800 | 8,800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | FRIEDMAN CATHY | RDUS | Restricted Stock Units | D | 4,800 | 4,800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 37.83 | 8,800 | 8,800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Restricted Stock Units | D | 4,800 | 4,800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 37.83 | 8,800 | 8,800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Graves Kurt | RDUS | Restricted Stock Units | D | 4,800 | 4,800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 37.83 | 8,800 | 8,800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 37.83 | 60,000 | 60,000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 37.83 | 60,000 | 60,000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 37.83 | 210,000 | 210,000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Hughes Owen | RDUS | Restricted Stock Units | D | 4,800 | 4,800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 37.83 | 8,800 | 8,800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 37.83 | 30,000 | 30,000 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Rosenberg Anthony | RDUS | Restricted Stock Units | D | 4,800 | 4,800 | ||||||
| 2018-02-15 | 2018-02-13 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 37.83 | 8,800 | 8,800 | |||||
| 2018-02-15 | 2018-02-13 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 37.83 | 60,000 | 60,000 | |||||
| 2018-02-12 | 2018-02-09 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34.3835 | 75,000 | 2,579 | 5,773,799 | ||||
| 2017-11-28 | 2017-11-27 | 4 | Kelly Joseph Francis | RDUS | Stock Option (Right to Buy) | D | 27.80 | 60,000 | 60,000 | |||||
| 2017-11-16 | 2017-11-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 26.2478 | 50,000 | 1,312 | 5,698,799 | ||||
| 2017-11-13 | 2017-11-10 | 4 | Hatzis-Schoch Brent | RDUS | Common Stock | D | 28.0893 | 1,778 | 50 | 2,278 | ||||
| 2017-11-07 | 2017-11-07 | 4 | Hoiland Jesper | RDUS | Common Stock | D | 29.0368 | 6,800 | 197 | 12,900 | ||||
| 2017-11-07 | 2017-11-03 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 29.1515 | 50,000 | 1,458 | 5,648,799 | ||||
| 2017-10-27 | 2017-10-26 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 30.9510 | 50,000 | 1,548 | 5,598,799 | ||||
| 2017-10-26 | 2017-10-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32.8483 | 50,000 | 1,642 | 5,548,799 | ||||
| 2017-09-15 | 2017-09-15 | 4 | Hoiland Jesper | RDUS | Common Stock | D | 32.7227 | 6,100 | 200 | 6,100 | ||||
| 2017-09-15 | 2017-09-14 | 4 | Carmona Jose | RDUS | Common Stock | D | 32.8343 | 3,000 | 99 | 3,000 | ||||
| 2017-09-15 | 2017-09-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32.9445 | 50,000 | 1,647 | 5,498,799 | ||||
| 2017-09-15 | 2017-09-13 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33.7075 | 100,000 | 3,371 | 5,448,799 | ||||
| 2017-09-13 | 2017-09-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35.4164 | 50,000 | 1,771 | 5,348,799 | ||||
| 2017-09-07 | 2017-09-05 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36.7525 | 50,000 | 1,838 | 5,298,799 | ||||
| 2017-08-18 | 2017-08-16 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35.9756 | 60,000 | 2,159 | 5,248,799 | ||||
| 2017-08-11 | 2017-08-10 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34.2600 | 75,000 | 2,570 | 5,188,799 | ||||
| 2017-08-11 | 2017-08-09 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35.6737 | 75,000 | 2,676 | 5,113,799 | ||||
| 2017-07-18 | 3 | Hoiland Jesper | RDUS | No securities are beneficially owned. | D | 0 | ||||||||
| 2017-07-18 | 2017-07-17 | 4 | Hoiland Jesper | RDUS | Stock Option (Right to Buy) | D | 42.97 | 305,000 | 305,000 | |||||
| 2017-05-31 | 2017-05-30 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34.2087 | 40,000 | 1,368 | 5,038,799 | ||||
| 2017-05-30 | 2017-05-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36.2505 | 40,000 | 1,450 | 4,998,799 | ||||
| 2017-05-22 | 2017-05-18 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 34.4069 | 50,000 | 1,720 | 4,958,799 | ||||
| 2017-05-18 | 2017-05-17 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 32.9812 | 18,000 | 594 | 4,908,799 | ||||
| 2017-05-18 | 2017-05-16 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33.9250 | 17,000 | 577 | 4,890,799 | ||||
| 2017-05-16 | 2017-05-15 | 4 | Carmona Jose | RDUS | Stock Option (Right to Buy) | D | 34.96 | 125,000 | 125,000 | |||||
| 2017-05-16 | 2017-05-12 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33.9997 | 15,000 | 510 | 4,873,799 | ||||
| 2017-05-11 | 2017-05-09 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35.9296 | 50,000 | 1,796 | 4,858,799 | ||||
| 2017-05-09 | 2017-05-08 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35.5978 | 22,800 | 812 | 4,808,799 | ||||
| 2017-05-09 | 2017-05-05 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35.5477 | 20,600 | 732 | 4,785,999 | ||||
| 2017-05-03 | 2017-05-02 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 33.9056 | 75,000 | 2,543 | 4,765,399 | ||||
| 2017-05-02 | 2017-05-01 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35.3907 | 150,000 | 5,309 | 4,690,399 | ||||
| 2017-04-27 | 2017-04-25 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to buy) | D | 2.74 | -11,838 | 0 | |||||
| 2017-04-27 | 2017-04-25 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to buy) | D | 2.74 | -27,778 | 0 | |||||
| 2017-04-27 | 2017-04-25 | 4 | Harvey Brian Nicholas | RDUS | Common Stock | D | 2.7400 | 39,616 | 109 | 76,189 | ||||
| 2017-03-22 | 2017-03-21 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 35.8325 | 50,000 | 1,792 | 4,540,399 | ||||
| 2017-03-22 | 2017-03-20 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 2.05 | -23,416 | 0 | |||||
| 2017-03-22 | 2017-03-20 | 4 | Harvey Brian Nicholas | RDUS | Common Stock | D | 2.0500 | 23,416 | 48 | 36,573 | ||||
| 2017-03-21 | 2017-03-17 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 38.4083 | 30,000 | 1,152 | 4,490,399 | ||||
| 2017-03-16 | 2017-03-15 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39.9560 | 44,469 | 1,777 | 4,460,399 | ||||
| 2017-03-16 | 2017-03-14 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39.9993 | 17,252 | 690 | 4,415,930 | ||||
| 2017-03-14 | 2017-03-10 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39.1673 | 38,279 | 1,499 | 4,398,678 | ||||
| 2017-02-22 | 2017-02-17 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 45.65 | 27,500 | 27,500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 45.65 | 27,500 | 27,500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Snow David P. | RDUS | Stock Option (Right to Buy) | D | 45.65 | 75,000 | 75,000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 45.65 | 187,800 | 187,800 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 45.65 | 75,000 | 75,000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 45.65 | 27,500 | 27,500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Fitzpatrick Lorraine A. | RDUS | Stock Option (Right to Buy) | D | 45.65 | 45,000 | 45,000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 45.65 | 27,500 | 27,500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 45.65 | 27,500 | 27,500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 45.65 | 27,500 | 27,500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 45.65 | 27,500 | 27,500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 45.65 | 55,000 | 55,000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 45.65 | 75,000 | 75,000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 45.65 | 60,000 | 60,000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 45.65 | 27,500 | 27,500 | |||||
| 2017-02-22 | 2017-02-17 | 4 | Purandare Dinesh | RDUS | Stock Option (Right to Buy) | D | 45.65 | 35,000 | 35,000 | |||||
| 2017-02-22 | 2017-02-17 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 45.65 | 27,500 | 27,500 | |||||
| 2016-10-25 | 2016-10-25 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 7.80 | -10,000 | 733,785 | |||||
| 2016-10-25 | 2016-10-25 | 4 | Ward Robert | RDUS | Common Stock | D | 7.8000 | 10,000 | 78 | 15,000 | ||||
| 2016-09-29 | 2016-09-27 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | -1,229,902 | 2,459,804 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | -1,229,902 | 2,459,804 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | GADICKE ANSBERT | RDUS | Common Stock | I | -1,943,751 | 3,887,502 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | EVNIN LUKE | RDUS | Common Stock | I | -1,943,751 | 3,887,502 | ||||||
| 2016-09-29 | 2016-09-27 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | -713,849 | 1,427,698 | ||||||
| 2016-06-02 | 2016-05-24 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 37.07 | 27,500 | 27,500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 37.07 | 27,500 | 27,500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 37.07 | 27,500 | 27,500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 37.07 | 27,500 | 27,500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 37.07 | 27,500 | 27,500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 37.07 | 27,500 | 27,500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 37.07 | 27,500 | 27,500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 37.07 | 27,500 | 27,500 | |||||
| 2016-06-02 | 2016-05-24 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 37.07 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 29.89 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 29.89 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 29.89 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 29.89 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 29.89 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 29.89 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 29.89 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 29.89 | 62,500 | 62,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 29.89 | 75,000 | 75,000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 29.89 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 29.89 | 156,250 | 156,250 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 29.89 | 75,000 | 75,000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Purandare Dinesh | RDUS | Stock Option (Right to Buy) | D | 29.89 | 75,000 | 75,000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Hatzis-Schoch Brent | RDUS | Stock Option (Right to Buy) | D | 29.89 | 62,500 | 62,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 29.89 | 27,500 | 27,500 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Fitzpatrick Lorraine A. | RDUS | Stock Option (Right to Buy) | D | 29.89 | 75,000 | 75,000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Snow David P. | RDUS | Stock Option (Right to Buy) | D | 29.89 | 75,000 | 75,000 | |||||
| 2016-01-26 | 2016-01-25 | 4 | Fitzpatrick Lorraine A. | RDUS | Common Stock | D | 37.9700 | 100 | 4 | 200 | ||||
| 2016-01-26 | 2015-11-25 | 4 | Fitzpatrick Lorraine A. | RDUS | Common Stock | D | 60.5950 | 100 | 6 | 100 | ||||
| 2016-01-25 | 2016-01-22 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 31.6658 | 38,259 | 1,212 | 4,360,399 | ||||
| 2016-01-14 | 2016-01-13 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 39.8977 | 50,000 | 1,995 | 4,322,140 | ||||
| 2015-12-07 | 2015-12-01 | 4 | GARNIER JEAN PIERRE | RDUS | Stock Option (Right to Buy) | D | 56.80 | 30,000 | 30,000 | |||||
| 2015-11-25 | 2015-11-23 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 7.80 | -25,000 | 743,785 | |||||
| 2015-11-25 | 2015-11-23 | 4 | Ward Robert | RDUS | Common Stock | D | 62.7650 | -25,000 | -1,569 | 0 | ||||
| 2015-11-25 | 2015-11-23 | 4 | Ward Robert | RDUS | Common Stock | D | 7.8000 | 25,000 | 195 | 25,000 | ||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2.74 | -1 | 0 | |||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2.74 | -5,682 | 0 | |||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Common Stock | D | 75.0000 | -5,683 | -426 | 0 | ||||
| 2015-11-13 | 2015-11-12 | 4 | Hattersley Gary | RDUS | Common Stock | D | 2.7400 | 5,683 | 16 | 0 | ||||
| 2015-11-05 | 2015-11-03 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2.74 | -13,333 | 0 | |||||
| 2015-11-05 | 2015-11-03 | 4 | Hattersley Gary | RDUS | Common Stock | D | 70.0000 | -13,333 | -933 | 0 | ||||
| 2015-11-05 | 2015-11-03 | 4 | Hattersley Gary | RDUS | Common Stock | D | 2.7400 | 13,333 | 37 | 0 | ||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 2.05 | -10,428 | 0 | |||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 3.42 | -874 | 0 | |||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Common Stock | D | 65.0000 | -11,302 | -735 | 0 | ||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Common Stock | D | 2.0500 | 10,428 | 21 | 10,428 | ||||
| 2015-10-27 | 2015-10-23 | 4 | Hattersley Gary | RDUS | Common Stock | D | 3.4200 | 874 | 3 | 874 | ||||
| 2015-10-23 | 2015-10-21 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 3.42 | -1,501 | 874 | |||||
| 2015-10-23 | 2015-10-21 | 4 | Hattersley Gary | RDUS | Common Stock | D | 65.3600 | -1,501 | -98 | 0 | ||||
| 2015-10-23 | 2015-10-21 | 4 | Hattersley Gary | RDUS | Common Stock | D | 3.4200 | 1,501 | 5 | 1,501 | ||||
| 2015-09-28 | 2015-09-14 | 4 | Snow David P. | RDUS | Common Stock | D | 69.7900 | 6,000 | 419 | 6,000 | ||||
| 2015-09-11 | 2015-09-09 | 4 | Snow David P. | RDUS | Stock Option (Right to Buy) | D | 65.23 | 100,000 | 100,000 | |||||
| 2015-09-11 | 2015-09-09 | 4 | Snow David P. | RDUS | Performance Units | D | 25,000 | 25,000 | ||||||
| 2015-09-08 | 2015-08-31 | 4 | Purandare Dinesh | RDUS | Common Stock | D | 62.2000 | 200 | 12 | 200 | ||||
| 2015-08-24 | 2015-08-21 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 63.4454 | 50,000 | 3,172 | 4,272,140 | ||||
| 2015-08-24 | 2015-08-20 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 64.5552 | 50,000 | 3,228 | 4,222,140 | ||||
| 2015-08-19 | 2015-08-17 | 4 | FRIEDMAN CATHY | RDUS | Stock Option (Right to Buy) | D | 72.51 | 30,000 | 30,000 | |||||
| 2015-08-19 | 2015-08-17 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7.34 | -22,694 | 2,723 | |||||
| 2015-08-19 | 2015-08-17 | 4 | Graves Kurt | RDUS | Common Stock | D | 70.0000 | -22,694 | -1,589 | 0 | ||||
| 2015-08-19 | 2015-08-17 | 4 | Graves Kurt | RDUS | Common Stock | D | 7.3400 | 22,694 | 167 | 22,694 | ||||
| 2015-08-12 | 2015-08-10 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7.34 | -2,306 | 25,417 | |||||
| 2015-08-12 | 2015-08-10 | 4 | Graves Kurt | RDUS | Common Stock | D | 70.0000 | -2,306 | -161 | 0 | ||||
| 2015-08-12 | 2015-08-10 | 4 | Graves Kurt | RDUS | Common Stock | D | 7.3400 | 2,306 | 17 | 2,306 | ||||
| 2015-07-29 | 2015-07-27 | 4 | Fitzpatrick Lorraine A. | RDUS | Stock Option (Right to Buy) | D | 73.76 | 150,000 | 150,000 | |||||
| 2015-07-27 | 2015-07-23 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 74.0000 | 250,000 | 18,500 | 4,172,140 | ||||
| 2015-07-20 | 2015-07-16 | 4 | Roychowdhury Debasish | RDUS | Stock Option (Right to Buy) | D | 77.64 | 30,000 | 30,000 | |||||
| 2015-07-08 | 2015-07-06 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7.34 | 25,000 | 27,723 | |||||
| 2015-07-08 | 2015-07-06 | 4 | Graves Kurt | RDUS | Common Stock | D | 69.4763 | -25,000 | -1,737 | 0 | ||||
| 2015-07-08 | 2015-07-06 | 4 | Graves Kurt | RDUS | Common Stock | D | 7.3400 | 25,000 | 184 | 25,000 | ||||
| 2015-06-22 | 2015-06-18 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 7.34 | 25,000 | 52,723 | |||||
| 2015-06-22 | 2015-06-18 | 4 | Graves Kurt | RDUS | Common Stock | D | 55.0500 | -25,000 | -1,376 | 0 | ||||
| 2015-06-22 | 2015-06-18 | 4 | Graves Kurt | RDUS | Common Stock | D | 7.3400 | 25,000 | 184 | 25,000 | ||||
| 2015-06-05 | 2015-06-04 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 7.80 | -5,000 | 788,974 | |||||
| 2015-06-05 | 2015-06-04 | 4 | Ward Robert | RDUS | Common Stock | D | 7.8000 | 5,000 | 39 | 5,000 | ||||
| 2015-05-26 | 2015-05-07 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 36.74 | 15,000 | 15,000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 36.74 | 15,000 | 15,000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Muenchbach Martin | RDUS | Stock Option (Right to Buy) | D | 36.74 | 15,000 | 15,000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 36.74 | 15,000 | 15,000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 36.74 | 15,000 | 15,000 | |||||
| 2015-05-26 | 2015-05-07 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 36.74 | 15,000 | 15,000 | |||||
| 2015-05-04 | 2015-05-01 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36.4593 | 50,000 | 1,823 | 3,922,140 | ||||
| 2015-04-30 | 3/A | Hatzis-Schoch Brent | RDUS | Common Stock | D | 500 | ||||||||
| 2015-04-30 | 2015-04-29 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36.2316 | 50,000 | 1,812 | 3,872,140 | ||||
| 2015-04-29 | 2015-04-27 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 38.3802 | 50,000 | 1,919 | 3,772,140 | ||||
| 2015-04-29 | 2015-04-28 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 36.5855 | 50,000 | 1,829 | 3,822,140 | ||||
| 2015-03-19 | 2015-03-18 | 4 | Purandare Dinesh | RDUS | Stock Option (Right to Buy) | D | 47.86 | 115,000 | 115,000 | |||||
| 2015-03-09 | 2015-03-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 47.0817 | 75,000 | 3,531 | 3,722,140 | ||||
| 2015-03-03 | 2015-03-02 | 4 | Rosenberg Anthony | RDUS | Stock Option (Right to Buy) | D | 44.18 | 60,000 | 60,000 | |||||
| 2015-02-27 | 2015-02-25 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 45.7386 | 35,000 | 1,601 | 3,647,140 | ||||
| 2015-02-26 | 3 | BB BIOTECH AG | RDUS | Common Stock | D | 7,224,280 | ||||||||
| 2015-02-26 | 3 | BB BIOTECH AG | RDUS | Common Stock | D | 7,224,280 | ||||||||
| 2015-02-26 | 3 | BB BIOTECH AG | RDUS | Common Stock | D | 7,224,280 | ||||||||
| 2015-01-20 | 2015-01-16 | 4/A | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 14.00 | -267,786 | 0 | |||||
| 2015-01-20 | 2015-01-16 | 4/A | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock Warrant | I | 14.00 | -121,396 | 0 | |||||
| 2015-01-20 | 2015-01-16 | 4/A | F2 Bioscience IV L.P. | RDUS | Common Stock Warrant | D | 14.00 | -249,932 | 0 | |||||
| 2015-01-20 | 2015-01-08 | 4/A | Jovan-Embiricos Morana By Fund | RDUS | Common Stock Warrant | I | 14.00 | -89,261 | 267,786 | |||||
| 2015-01-20 | 2015-01-08 | 4/A | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 14.00 | -89,261 | 267,786 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock Warrant | I | 2.69 | -121,396 | 0 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock Warrant | D | 2.69 | -249,932 | 0 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock | I | -871,851 | 0 | ||||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | D | -1,794,983 | 0 | ||||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 2.69 | -267,786 | 0 | |||||
| 2015-01-16 | 2015-01-16 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock | D | -1,167,997 | 0 | ||||||
| 2015-01-15 | 2014-07-15 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock | I | -335,820 | 0 | ||||||
| 2015-01-15 | 2014-07-10 | 4 | F2 Bioscience IV L.P. By Fund | RDUS | Common Stock | I | -251,680 | 335,820 | ||||||
| 2015-01-15 | 2014-07-15 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | -335,820 | 0 | ||||||
| 2015-01-15 | 2014-07-10 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | -251,680 | 335,820 | ||||||
| 2015-01-12 | 2015-01-08 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock Warrant | D | 2.69 | -89,261 | 267,786 | |||||
| 2015-01-12 | 2015-01-08 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock | D | -389,331 | 1,167,997 | ||||||
| 2015-01-12 | 2015-01-08 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock Warrant | I | 2.69 | -89,261 | 267,786 | |||||
| 2015-01-12 | 2015-01-08 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | -389,331 | 1,167,997 | ||||||
| 2014-12-19 | 2014-12-17 | 4 | GADICKE ANSBERT | RDUS | Stock Option (Right to Buy) | D | 30.97 | 30,000 | 30,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Williams Gregory C. | RDUS | Stock Option (Right to Buy) | D | 30.97 | 80,000 | 80,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 30.97 | 100,000 | 100,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Stoner Elizabeth | RDUS | Stock Option (Right to Buy) | D | 30.97 | 30,000 | 30,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 30.97 | 30,000 | 30,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Muenchbach Martin | RDUS | Stock Option (Right to Buy) | D | 30.97 | 30,000 | 30,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Harvey Brian Nicholas | RDUS | Stock Option (Right to Buy) | D | 30.97 | 50,000 | 50,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | AUERBACH ALAN H | RDUS | Stock Option (Right to Buy) | D | 30.97 | 30,000 | 30,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | HARRIS ALAN G | RDUS | Stock Option (Right to Buy) | D | 30.97 | -50,000 | 50,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Ward Robert | RDUS | Stock Option (Right to Buy) | D | 30.97 | 215,000 | 215,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Jovan-Embiricos Morana | RDUS | Stock Option (Right to Buy) | D | 30.97 | 30,000 | 30,000 | |||||
| 2014-12-19 | 2014-12-17 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 30.97 | 30,000 | 30,000 | |||||
| 2014-11-07 | 2014-11-01 | 4 | Dere Willard H | RDUS | Stock Option (Right to Buy) | D | 18.41 | 30,000 | 30,000 | |||||
| 2014-06-23 | 2014-06-19 | 4 | HARRIS ALAN G | RDUS | Employee Stock Option (Right to Buy) | D | 8.78 | 50,000 | 50,000 | |||||
| 2014-06-13 | 2014-06-11 | 4 | Muenchbach Martin By Fund | RDUS | Series B-2 Convertible Preferred Stock | I | -12,211 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Muenchbach Martin By Fund | RDUS | Common Stock | I | 96,160 | 1,393,443 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Series B-2 Convertible Preferred Stock | I | -110,713 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Series B-2 Convertible Preferred Stock | I | -227,938 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 8.0000 | 587,500 | 4,700 | 587,500 | ||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 871,851 | 871,851 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 1,794,983 | 1,794,983 | ||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1,175,000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1,175,000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1,175,000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1,175,000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1,175,000 | ||||||||
| 2014-06-13 | 3 | F2 Bioscience IV GP Ltd. | RDUS | Common Stock | D | 1,175,000 | ||||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Series B-2 Convertible Preferred Stock | I | -110,713 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Series B-2 Convertible Preferred Stock | D | -227,938 | 0 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | I | 8.0000 | 587,500 | 4,700 | 587,500 | ||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | I | 871,851 | 871,851 | ||||||
| 2014-06-13 | 2014-06-11 | 4 | F2 Bioscience IV L.P. | RDUS | Common Stock | D | 1,794,983 | 1,794,983 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Series B-2 Convertible Preferred Stock | D | -65,125 | 0 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Series B Convertible Preferred Stock | D | -97,688 | 0 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Series A-1 Convertible Preferred Stock | D | -122,820 | 0 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 8.0000 | 1,000,000 | 8,000 | 2,705,040 | ||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 187,262 | 1,705,040 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 500,029 | 1,517,778 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 428,459 | 1,017,749 | ||||||
| 2014-06-12 | 2014-06-06 | 4 | BIOTECH GROWTH N V | RDUS | Common Stock | D | 589,290 | 589,290 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -105,162 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -84,536 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Series B Convertible Preferred Stock | I | -32,563 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Muenchbach Martin By Fund | RDUS | Common Stock | I | 1,297,283 | 1,297,283 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -184,242 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -114,537 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -71,638 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -859 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -3,511 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -4,346 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -1,468 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -1,340 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -5,477 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -6,779 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -2,291 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -3,752 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -15,327 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -18,975 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -6,414 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -44,395 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -181,364 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -224,528 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -75,899 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-3 Convertible Preferred Stock | I | -2,985 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-2 Convertible Preferred Stock | I | -12,194 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series A-1 Convertible Preferred Stock | I | -15,096 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Series B Convertible Preferred Stock | I | -5,103 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 2,141,547 | 2,141,547 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 59,445 | 59,445 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 92,734 | 92,734 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 259,567 | 259,567 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 3,071,454 | 3,071,454 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GADICKE ANSBERT By Fund | RDUS | Common Stock | I | 206,506 | 206,506 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series B Convertible Preferred Stock | I | -162,813 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series A-3 Convertible Preferred Stock | I | -53,331 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series A-2 Convertible Preferred Stock | I | -402,115 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Series A-1 Convertible Preferred Stock | I | -384,261 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 1,088,251 | 5,831,253 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 714,095 | 4,743,002 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 255,881 | 4,028,907 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 1,929,344 | 3,773,026 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | EVNIN LUKE | RDUS | Common Stock | I | 1,843,682 | 1,843,682 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series B Convertible Preferred | I | -91,175 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series A-3 Convertible Preferred Stock | I | -53,331 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series A-2 Convertible Preferred Stock | I | -217,873 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Series A-1 Convertible Preferred Stock | I | -269,724 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 694,449 | 3,689,706 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 399,891 | 2,995,257 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 255,881 | 2,595,366 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 1,045,351 | 2,339,485 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock | I | 1,294,134 | 1,294,134 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series B Convertible Preferred | I | -91,175 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series A-3 Convertible Preferred Stock | I | -53,331 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series A-2 Convertible Preferred Stock | I | -217,873 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Series A-1 Convertible Preferred Stock | I | -269,724 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 694,449 | 3,689,706 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 399,891 | 2,995,257 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 255,881 | 2,595,366 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 1,045,351 | 2,339,485 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock | I | 1,294,134 | 1,294,134 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Series B Convertible Preferred Stock | I | -71,638 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Series A-2 Convertible Preferred Stock | I | -184,242 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Series A-1 Convertible Preferred Stock | I | -114,537 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 393,802 | 2,141,547 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 314,204 | 1,747,745 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 883,993 | 1,433,541 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock | I | 549,548 | 549,548 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Series B Convertible Preferred Stock | I | -325,627 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | Jovan-Embiricos Morana By Fund | RDUS | Common Stock | I | 1,557,328 | 1,557,328 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | F2 Bioscience III, L.P. | RDUS | Series B Convertible Preferred Stock | D | -325,627 | 0 | ||||||
| 2014-06-10 | 2014-06-06 | 4 | F2 Bioscience III, L.P. | RDUS | Common Stock | D | 1,557,328 | 1,557,328 | ||||||
| 2014-06-09 | 2014-06-05 | 4 | Graves Kurt | RDUS | Stock Option (Right to Buy) | D | 8.00 | 65,789 | 65,789 | |||||
| 2014-06-09 | 2014-06-05 | 4 | HARRIS ALAN G | RDUS | Stock Option (Right to Buy) | D | 8.00 | 131,578 | 131,578 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Durand Mark | RDUS | Stock Option (Right to Buy) | D | 8.00 | 175,438 | 175,438 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Bain Capital Public Equity Management, LLC | NONE | Common Stock | I | 8.0000 | 500,000 | 4,000 | 1,943,241 | ||||
| 2014-06-09 | 2014-06-05 | 4 | Hattersley Gary | RDUS | Stock Option (Right to Buy) | D | 8.00 | 120,614 | 120,614 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Hughes Owen | RDUS | Stock Option (Right to Buy) | D | 8.00 | 32,894 | 32,894 | |||||
| 2014-04-01 | 2014-03-28 | 4 | Bain Capital Public Equity Management, LLC | NONE | Common Stock Warrants | I | 6.14 | 6.1420 | 67,160 | 412 | 67,160 | |||
| 2014-04-01 | 2014-03-28 | 4 | Bain Capital Public Equity Management, LLC | NONE | Series B-2 Convertible Preferred Stock | I | 61.4200 | 26,684 | 1,639 | 26,684 | ||||
| 2014-04-01 | 2013-04-23 | 4 | Bain Capital Public Equity Management, LLC | NONE | Common Stock Warrants | I | 6.14 | 6.1420 | 203,518 | 1,250 | 203,518 | |||
| 2014-04-01 | 2013-04-23 | 4 | Bain Capital Public Equity Management, LLC | NONE | Series B Convertible Preferred Stock | I | 61.4200 | 81,407 | 5,000 | 81,407 | ||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Common Stock Warrant | I | 6.14 | 276,783 | 276,783 | |||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Common Stock Warrant | I | 6.14 | 569,845 | 569,845 | |||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Series B-2 Convertible Preferred Stock | I | 61.4200 | 110,713 | 6,800 | 110,713 | ||||
| 2014-02-21 | 2014-02-14 | 4 | F2 Capital Ltd | NONE | Series B-2 Convertible Preferred Stock | I | 61.4200 | 227,938 | 14,000 | 227,938 | ||||
| 2014-02-21 | 2014-02-19 | 4 | BIOTECH GROWTH N V | NONE | Common Stock Warrant | D | 6.14 | 162,813 | 162,813 | |||||
| 2014-02-21 | 2014-02-19 | 4 | BIOTECH GROWTH N V | NONE | Series B-2 Convertible Preferred Stock | D | 61.4200 | 65,125 | 4,000 | 65,125 | ||||
| 2014-02-19 | 2014-02-14 | 4 | Muenchbach Martin By Fund | NONE | Common Stock Warrant | I | 6.14 | 30,528 | 111,936 | |||||
| 2014-02-19 | 2014-02-14 | 4 | Muenchbach Martin By Fund | NONE | Series B-2 Convertible Preferred Stock | I | 61.4200 | 12,211 | 750 | 12,211 | ||||
| 2014-02-19 | 2014-02-16 | 4 | Yates John | NONE | Stock Option (Right to Buy) | D | 3.42 | 3.4200 | 300,000 | 1,026 | 300,000 | |||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Common Stock Warrant | I | 6.14 | 276,783 | 276,783 | |||||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Common Stock Warrant | I | 6.14 | 569,845 | 569,845 | |||||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Series B-2 Convertible Preferred Stock | I | 61.4200 | 110,713 | 6,800 | 110,713 | ||||
| 2014-02-19 | 2014-02-14 | 4 | Jovan-Embiricos Morana By Fund | NONE | Series B-2 Convertible Preferred Stock | I | 61.4200 | 227,938 | 14,000 | 227,938 | ||||
| 2014-02-19 | 2014-02-16 | 4 | Ward Robert | NONE | Stock Option (Right to Buy) | D | 3.42 | 3.4200 | 97,199 | 332 | 97,199 | |||
| 2014-02-19 | 2014-02-16 | 4 | Ward Robert | NONE | Stock Option (Right to Buy) | D | 3.42 | 3.4200 | 1,810,262 | 6,191 | 1,810,262 | |||
| 2014-02-19 | 2014-02-16 | 4 | Williams Gregory C. | NONE | Stock Option (Right to Buy) | D | 3.42 | 3.4200 | 400,000 | 1,368 | 400,000 | |||
| 2014-01-06 | 2013-12-31 | 4 | Nordic Bioscience Clinical Development VII A/S | NONE | Series A-6 Convertible Preferred Stock | D | 496,111 | 5,025,540 | ||||||
| 2013-12-06 | 3 | Lyttle Cecil Richard | NONE | Common Stock | D | 66,666 | ||||||||
| 2013-11-18 | 2013-11-14 | 4 | Fromkin Andrew J. | NONE | Stock Option (Right to Buy) | D | 3.45 | 3.4500 | 2,427,133 | 8,374 | 2,427,133 | |||
| 2013-04-30 | 2013-04-23 | 4 | EVNIN LUKE | RDUS | Common Stock Warrant | I | 6.14 | 6.1420 | 407,034 | 2,500 | 0 | |||
| 2013-04-30 | 2013-04-23 | 4 | EVNIN LUKE | RDUS | Series B Convertible Preferred Stock | I | 61.4200 | 162,813 | 10,000 | 0 | ||||
| 2013-04-30 | 2013-04-23 | 4 | MPM BIOVENTURES III LLC | RDUS | Common Stock Warrant | I | 6.14 | 6.1420 | 227,939 | 1,400 | 227,939 | |||
| 2013-04-30 | 2013-04-23 | 4 | MPM BIOVENTURES III LLC | RDUS | Series B Convertible Preferred Stock | I | 61.4200 | 91,175 | 5,600 | 91,175 | ||||
| 2013-04-30 | 2013-04-23 | 4 | GALAKATOS NICHOLAS | RDUS | Common Stock Warrant | I | 6.14 | 6.1420 | 227,939 | 1,400 | 0 | |||
| 2013-04-30 | 2013-04-23 | 4 | GALAKATOS NICHOLAS | RDUS | Series B Convertible Preferred Stock | I | 61.4200 | 91,175 | 5,600 | 0 | ||||
| 2013-04-30 | 2013-04-23 | 4 | MPM BioVentures IV LLC | RDUS | Common Stock Warrant | I | 6.14 | 6.1420 | 179,095 | 1,100 | 179,095 | |||
| 2013-04-30 | 2013-04-23 | 4 | MPM BioVentures IV LLC | RDUS | Series B Convertible Preferred Stock | I | 61.4200 | 71,638 | 4,400 | 71,638 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6.14 | 179,095 | 179,095 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61.4200 | 71,638 | 4,400 | 71,638 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6.14 | 3,670 | 3,670 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61.4200 | 1,468 | 90 | 1,468 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6.14 | 5,728 | 5,728 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61.4200 | 2,291 | 141 | 2,291 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6.14 | 16,035 | 16,035 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61.4200 | 6,414 | 394 | 6,414 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6.14 | 189,748 | 189,748 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61.4200 | 75,899 | 4,662 | 75,899 | ||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Common Stock Warrant | I | 6.14 | 12,758 | 12,758 | |||||
| 2013-04-25 | 2013-04-23 | 4 | GADICKE ANSBERT By Fund | NONE | Series B Convertible Preferred Stock | I | 61.4200 | 5,103 | 313 | 5,103 | ||||
| 2013-04-25 | 2013-04-23 | 4 | Muenchbach Martin By Fund | NONE | Common Stock Warrant | I | 6.14 | 81,408 | 81,408 | |||||
| 2013-04-25 | 2013-04-23 | 4 | Muenchbach Martin By Fund | NONE | Series B Convertible Preferred Stock | I | 61.4200 | 32,563 | 2,000 | 32,563 | ||||
| 2013-04-25 | 2013-04-23 | 4 | BIOTECH GROWTH N V | NONE | Common Stock Warrant | D | 6.14 | 244,220 | 244,220 | |||||
| 2013-04-25 | 2013-04-23 | 4 | BIOTECH GROWTH N V | NONE | Series B Convertible Preferred Stock | D | 61.4200 | 97,688 | 6,000 | 97,688 | ||||
| 2012-09-28 | 2011-12-15 | 4 | BRENNER LOUIS MD | NONE | Stock Option (Right to Buy) | D | 3.89 | 3.8900 | 62,700 | 244 | 451,700 | |||
| 2012-09-28 | 2011-12-15 | 4 | BRENNER LOUIS MD | NONE | Stock Option (Right to Buy) | D | 3.89 | 3.8900 | 37,600 | 146 | 389,000 | |||
| 2012-09-28 | 2011-12-15 | 4 | BRENNER LOUIS MD | NONE | Stock Option (Right to Buy) | D | 3.89 | 3.8900 | 351,400 | 1,367 | 351,400 | |||
| 2012-06-22 | 2011-12-15 | 4 | WYZGA MICHAEL S | NONE | Stock Option (Right to Buy) | D | 3.89 | 3.8900 | -1,530,000 | -5,952 | 1,530,000 | |||
| 2012-06-19 | 2012-04-11 | 4 | Franken Michael | NONE | Stock Option (Right to Buy) | D | 4.21 | 4.2100 | 70,000 | 295 | 70,000 | |||
| 2012-02-02 | 2011-12-14 | 5 | Bain Capital Public Equity Management, LLC | NONE | Series A-1 Convertible Preferred Stock | I | 81.4200 | 40,940 | 3,333 | 122,820 | ||||
| 2012-02-02 | 2011-11-18 | 5 | Bain Capital Public Equity Management, LLC | NONE | Series A-1 Convertible Preferred Stock | I | 81.4200 | 40,940 | 3,333 | 81,880 | ||||
| 2011-05-24 | 3 | CAVANAUGH JAMES H | NONE | Common Stock | D | 83,113 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
